Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3117391 in Subjects With Rheumatoid Arthritis
Clinical trial NCT02965599 · TERMINATED
Trial details
- NCT number
- NCT02965599
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-27
- Primary completion
- 2017-11-14
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.